/

Immunology and Infection

/

Détection de l’anticorps du domaine de liaison au récepteur du SARS-CoV-2 à l’aide d’un biorapporteur basé sur HiBiT

JoVE Journal
Immunology and Infection

A subscription to JoVE is required to view this content. Sign in or start your free trial.

JoVE Journal Immunology and Infection

Detection of SARS-CoV-2 Receptor-Binding Domain Antibody using a HiBiT-Based Bioreporter

Please note that all translations are automatically generated. Click here for the English version.

Détection de l’anticorps du domaine de liaison au récepteur du SARS-CoV-2 à l’aide d’un biorapporteur basé sur HiBiT

2,901 Views

•

07:44 min

•

August 12, 2021

DOI:

10.3791/62488-v

DOI:

10.3791/62488-v

•

07:44 min

August 12, 2021

•

14 Views

Reza Rezaei², Abera Surendran², Ragunath Singaravelu², Taylor R. Jamieson², Parisa Taklifi, Joanna Poutou², Taha Azad², Carolina S. Ilkow²

¹Ottawa Hospital Research Institute, ²Department of Biochemistry, Microbiology and Immunology,University of Ottawa, ³Department of Biotechnology,University of Tehran

Tags

SARS-CoV-2 Receptor-binding Domain Antibody Detection HiBiT-based Bioreporter COVID-19 Research High-throughput Assay Cell Culture Transfection Passive Lysis Buffer

Read Article